# Nuclide record bone-hydroxyapatite (target). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/targets/bone-hydroxyapatite/>
  a schema:BioChemEntity ;
  nuclide:kind "target" ;
  schema:identifier "bone-hydroxyapatite" ;
  schema:name "Bone mineral (hydroxyapatite)"@en ;
  schema:alternateName "Hydroxyapatite"@en, "bone mineral matrix"@en ;
  schema:description "The hard mineral that makes up bone. Certain radioactive drugs stick to this mineral wherever bone is being actively rebuilt, which is how bone scans find fractures, infection and cancer that has spread to bone, and how some treatments deliver radiation straight to bone metastases."@en ;
  schema:url <https://nuclide.cc/targets/bone-hydroxyapatite/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.ncbi.nlm.nih.gov/books/NBK531486/>, <https://www.mdpi.com/1422-0067/25/1/462>, <https://ame.nd.edu/research-legacy/faculty-research-labs/rroeder/publications/publication-pdf/2016%20ADDR%20Cole.pdf>, <https://jnm.snmjournals.org/content/jnumed/early/2013/03/11/jnumed.112.114298.full.pdf> ;
  nuclide:tag "bone", "mineral", "palliation" ;
  nuclide:targetClass "other" ;
  nuclide:related <https://nuclide.cc/drugs/samarium-153-lexidronam/>, <https://nuclide.cc/drugs/radium-223/>, <https://nuclide.cc/drugs/phosphorus-32/>, <https://nuclide.cc/technologies/spect/>, <https://nuclide.cc/terms/bone-metastases/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/tc-99m/>, <https://nuclide.cc/isotopes/ra-223/>, <https://nuclide.cc/isotopes/sm-153/> .